Skip to main content
. 2025 May 1;25(2):1–177.

Table 49:

Volume of Intervention, Migraine

Volume, n Year 1 Year 2 Year 3 Year 4 Year 5
Ontario adult and adolescent population (aged 12 to 90+ years)a 14,180,195 14,482,945 14,727,596 14,921,727 15,124,605
Population with migraine (8.8% prevalence)b 1,247,857 1,274,499 1,296,028 1,313,112 1,330,965
Population eligible for nVNS treatment (90% of the population with migraine)c 1,123,071 1,147,049 1,166,425 1,181,800 1,197,869
Population eligible for acute treatment (100%) 1,123,071 1,147,049 1,166,425 1,181,800 1,197,869
Population eligible for prevention (25%) 280,768 286,762 291,606 295,450 299,467

Abbreviation: nVNS, noninvasive vagus nerve stimulation.

a

Ministry of Finance population projections, 2023.110

b

Ramage-Morin et al, 2014.7

c

M. Lagman, MD, email communication, December 2023.